The DES Center

Filter Your Results

 

News

 

Medtronic Launches Resolute Onyx Drug-Eluting Stent in United States

May 1, 2017 -- Medtronic announced the US Food and Drug Administration (FDA) approval and the United States launch of the Resolute Onyx drug-eluting stent (DES). The Reso…

DUTCH PEERS Data Evaluate Newer-Generation DES at 3 Years

April 24, 2017 -- A report assessing the 3-year safety and efficacy of implanting newer-generation Resolute Integrity zotarolimus-eluting stents (ZES; Medtronic) versus P…

Reva Medical's Fantom Bioresorbable Coronary Scaffold Approved in Europe

April 10, 2017 -- Reva Medical, Inc. announced it has received European CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold. Fantom is Reva’s fi…

ECLIPSE Trial of CSI's Orbital Atherectomy System Begins Enrollment

March 28, 2017 -- Cardiovascular Systems, Inc. (CSI), in partnership with the Cardiovascular Research Foundation, announced the commencement of enrollment in the ECLIPSE clini…

PROTECT Evaluates DES Implantation in Left Anterior Descending Artery

March 27, 2017 -- Ariel Roguin, MD, et al published long-term outcomes of the PROTECT (Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial) trial in …

BIOFLOW-IV Data Presented in Japan for Biotronik's Orsiro DES

March 23, 2017 -- Biotronik announced that 12-month results of the BIOFLOW-IV clinical study of the company's Orsiro hybrid drug-eluting stent (DES) were presented at the …

Abbott Vascular's 2-Year ABSORB III Data Presented; FDA Issues Warning Letter

March 18, 2017 -- Abbott Vascular announced that data from ABSORB III, the company's United States pivotal trial of its Absorb bioresorbable vascular scaffold, showed…

Biosensors’ LEADERS FREE II BioFreedom Pivotal Study Begins Enrollment

February 15, 2017 -- Biosensors International Group, Ltd. announced that it has started enrollment in the new BioFreedom pivotal study, called LEADERS FREE II. The study …

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.